Related references
Note: Only part of the references are listed.From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding
Nicolas H. Thurin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Comparison of risks of arterial thromboembolic events and glaucoma with ranibizumab and aflibercept intravitreous injection: A nationwide population-based cohort study
Yin-Hsi Chang et al.
PLOS ONE (2022)
VEGFR1 signaling in retinal angiogenesis and microinflammation
Akiyoshi Uemura et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2021)
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial
Ahmad A. Aref et al.
JAMA OPHTHALMOLOGY (2021)
Intraocular Pressure Elevation Following Intravitreal Anti-VEGF Injections: Short- and Long-term Considerations
Ariana M. Levin et al.
JOURNAL OF GLAUCOMA (2021)
Use of anti-vascular endothelial growth factor drugs for eye disease in Tuscany: Development and test of indicators of treatment intensity
Gianni Virgili et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2020)
Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice Data from the Fight Retinal Blindness! Registry
Pierre-Henry Gabrielle et al.
OPHTHALMOLOGY RETINA (2020)
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?
Gianluca Trifiro et al.
DRUG SAFETY (2019)
Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study
Michele Augsburger et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases
Tine Van Bergen et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2019)
The Real-World Effect of Intravitreous Anti-Vascular Endothelial Growth Factor Drugs on Intraocular Pressure An Analysis Using the IRIS Registry
Elizabeth A. Atchison et al.
OPHTHALMOLOGY (2018)
Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery
Brennan D. Eadie et al.
JAMA OPHTHALMOLOGY (2017)
Changes in intraocular pressure in study and fellow eyes in the IVAN trial
Alexander J. E. Foss et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2016)
Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis
Yandan Zhou et al.
SCIENTIFIC REPORTS (2016)
Intraocular Pressure in Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept or Ranibizumab
K. Bailey Freund et al.
OPHTHALMOLOGY (2015)
Intraocular Pressure in Eyes Receiving Monthly Ranibizumab in 2 Pivotal Age-Related Macular Degeneration Clinical Trials
Sophie J. Bakri et al.
OPHTHALMOLOGY (2014)
Inhibition of placental growth factor improves surgical outcome of glaucoma surgery
Tine Van Bergen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
Tim U. Krohne et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents
Travis J. Good et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Silicone Oil Microdroplets and Protein Aggregates in Repackaged Bevacizumab and Ranibizumab: Effects of Long-term Storage and Product Mishandling
Lu Liu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)